Proteomics portrait of archival lesions of chronic pancreatitis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Pan, Sheng ^a   Chen, Ru ^a   Stevens, Tyler ^b   Bronner, Mary P ^c   May, Damon ^d   Tamura, Yasuko ^a   McIntosh, Martin W ^d   Brentnall, Teresa A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 14A1; GLYCOPROTEIN; LUMICAN; PROTHROMBIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG; VERSICAN; COL14A1 PROTEIN, HUMAN; KERATAN SULFATE; PROTEIN; PROTEOCHONDROITIN SULFATE; SCLEROPROTEIN;

ACINAR CELL; ACUTE PHASE RESPONSE; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEOMICS; ADENOCARCINOMA; CLUSTER ANALYSIS; HEALTH CARE FACILITY; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; REPRODUCIBILITY; SIGNAL TRANSDUCTION; STAINING;

ACINAR CELLS; ADENOCARCINOMA; BIOLOGICAL SPECIMEN BANKS; CHONDROITIN SULFATE PROTEOGLYCANS; CLUSTER ANALYSIS; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATAN SULFATE; PANCREAS; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; PANCREATITIS, CHRONIC; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STAINING AND LABELING; VERSICANS;

EID: 81755171923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027574     Document Type: Article

References (60)

1. Bhuiya FA, Pitts SR, McCaig LF, (2010) Emergency department visits for chest pain and abdominal pain: United States, 1999-2008. NCHS Data Brief pp. 1-8.
2. Everhart JE, Ruhl CE, (2009) Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 136: 1134-1144.
3. Spanier BW, Dijkgraaf MG, Bruno MJ, (2008) Trends and forecasts of hospital admissions for acute and chronic pancreatitis in the Netherlands. Eur J Gastroenterol Hepatol 20: 653-658.
4. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, et al. (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328: 1433-1437.
5. Lowenfels AB, Maisonneuve P, Dimagno EP, Elitsur Y, Gates LK, et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89: 442-446.
6. Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, et al. (2002) Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51: 849-852.
7. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, et al. (2003) p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol 27: 1495-1501.
8. Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, et al. (2007) Quantitative Proteomics Analysis Reveals That Proteins Differentially Expressed in Chronic Pancreatitis Are Also Frequently Involved in Pancreatic Cancer. Mol Cell Proteomics 6: 1331-1342.
9. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, et al. (2005) Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129: 1454-1463.
10. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, et al. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5: 157-171.
11. Chen R, Pan S, Aebersold R, Brentnall T, (2007) Proteomics studies of pancreatic cancer. Proteomics Clin Appl 1: 1582-1591.
12. Chen R, Pan S, Brentnall TA, Aebersold R, (2005) Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 4: 523-533.
13. Grantzdorffer I, Carl-McGrath S, Ebert MP, Rocken C, (2008) Proteomics of pancreatic cancer. Pancreas 36: 329-336.
14. Lohr M, Faissner R, (2004) Proteomics in pancreatic disease. Pancreatology 4: 67-75.
15. Vimalachandran D, Costello E, (2004) Proteomic technologies and their application to pancreatic cancer. Expert Rev Proteomics 1: 493-501.
16. Chen JH, Ni RZ, Xiao MB, Guo JG, Zhou JW, (2009) Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat Dis Int 8: 193-200.
17. Chen R, Yi EC, Donohoe D, Pan S, Eng J, et al. (2005) Pancreatic Cancer Proteome: the Proteins that Underlie Invasion, Metastasis, and Immunologic Escape. Gastroenterology 129: 1187-1197.
18. Cui Y, Wu J, Zong M, Song G, Jia Q, et al. (2009) Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer 124: 1614-1621.
19. Cui Y, Tian M, Zong M, Teng M, Chen Y, et al. (2009) Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma. Pancreatology 9: 89-98.
20. Dai L, Li C, Shedden KA, Lee CJ, Li C, et al. (2010) Quantitative proteomic profiling studies of pancreatic cancer stem cells. J Proteome Res 9: 3394-3402.
21. Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, et al. (2007) Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 30: 849-855.
22. Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, et al. (2009) Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis 30: 1132-1144.
23. Scarlett CJ, Smith RC, Saxby A, Nielsen A, Samra JS, et al. (2006) Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology 130: 1670-1678.
24. Addis MF, Tanca A, Pagnozzi D, Crobu S, Fanciulli G, et al. (2009) Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 9: 3815-3823.
25. Balgley BM, Guo T, Zhao K, Fang X, Tavassoli FA, et al. (2009) Evaluation of archival time on shotgun proteomics of formalin-fixed and paraffin-embedded tissues. J Proteome Res 8: 917-925.
26. Blonder J, Veenstra TD, (2009) Clinical proteomic applications of formalin-fixed paraffin-embedded tissues. Clin Lab Med 29: 101-113.
27. Hood BL, Conrads TP, Veenstra TD, (2006) Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within. Proteomics 6: 4106-4114.
28. Hwang SI, Thumar J, Lundgren DH, Rezaul K, Mayya V, et al. (2007) Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 26: 65-76.
29. Sprung RW, Brock JW, Tanksley JP, Li M, Washington MK, et al. (2009) Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 8: 1988-1998.
30. Albashir S, Bronner MP, Parsi MA, Walsh RM, Stevens T, (2010) Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol 105: 2498-2503.
31. Ammann RW, Heitz PU, Kloppel G, (1996) Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 111: 224-231.
32. May D, Pan S, Crispin DA, Lai K, Bronner MP, et al. (2011) Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res 10: 200-209.
33. Craig R, Beavis RC, (2004) TANDEM: matching proteins with tandem mass spectra. Bioinformatics 20: 1466-1467.
34. Keller A, Eng J, Zhang N, Li XJ, Aebersold R, (2005) A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 1: 2005.
35. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Analytical Chemistry 74: 5383-5392.
36. May D, Fitzgibbon M, Liu Y, Holzman T, Eng J, et al. (2007) A platform for accurate mass and time analyses of mass spectrometry data. J Proteome Res 6: 2685-2694.
37. Bellew M, Coram M, Fitzgibbon M, Igra M, Randolph T, et al. (2006) A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics 22: 1902-1909.
38. May D, Liu Y, Law W, Fitzgibbon M, Wang H, et al. (2008) Peptide Sequence Confidence in Accurate Mass and Time Analysis and Its Use in Complex Proteomics Experiments. J Proteome Res.
39. Wang P, Tang H, Zhang H, Whiteaker J, Paulovich AG, et al. (2006) Normalization regarding non-random missing values in high-throughput mass spectrometry data. Pac Symp Biocomput pp. 315-326.
40. Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, et al. (2010) A guided tour of the Trans-Proteomic Pipeline. Proteomics 10: 1150-1159.
41. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
42. Huang dW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
43. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T, (2007) Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 22: 1167-1174.
44. Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R, (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61: 198-223.
45. Greenberger NJ, Toskes PP, (2008) Chapter 307. Acute and Chronic Pancreatitis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, editors. Medicine Harrison's Principles of Internal Medicine 17e.
46. Pawlak G, Helfman DM, (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11: 41-47.
47. Van Acker GJ, Saluja AK, Bhagat L, Singh VP, Song AM, et al. (2002) Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity. Am J Physiol Gastrointest Liver Physiol 283: G794-G800.
48. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, et al. (1990) Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A 87: 3811-3815.
49. Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, et al. (2001) Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 32: 1174-1183.
50. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, et al. (2001) Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 234: 769-778.
51. Ozaki N, Ohmuraya M, Hirota M, Ida S, Wang J, et al. (2009) Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol Cancer Res 7: 1572-1581.
52. Shimosegawa T, Kume K, Satoh K, (2009) Chronic pancreatitis and pancreatic cancer: prediction and mechanism. Clin Gastroenterol Hepatol 7: S23-S28.
53. Chen R, Pan S, Yi EC, Donohoe S, Bronner MP, et al. (2006) Quantitative proteomic profiling of pancreatic cancer juice. Proteomics 6: 3871-3879.
54. Pan S, Chen R, Crispin DA, May D, Stevens T, et al. (2011) Protein Alterations Associated with Pancreatic Cancer and Chronic Pancreatitis Found in Human Plasma using Global Quantitative Proteomics Profiling. J Proteome Res.
55. Shimizu K, (2008) Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 43: 823-832.
56. Agarwal AK, Raj KK, Agarwal S, Singh S, (2008) Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg 196: 149-154.
57. Weber SM, Rikkers LF, (2003) Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World J Surg 27: 1271-1274.
58. Ping LY, Ishiwata T, Asano G, (2002) Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J Pathol 196: 324-330.
59. Koninger J, Giese T, di Mola FF, Wente MN, Esposito I, et al. (2004) Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun 322: 943-949.
60. Ishiwata T, Cho K, Kawahara K, Yamamoto T, Fujiwara Y, et al. (2007) Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer. Oncol Rep 18: 537-543.